Related Experiment Videos
Pancreatic masses with inconclusive findings on spiral CT: is there a role for MRI?
R C Semelka1, N L Kelekis, P L Molina
1Department of Radiology, University of North Carolina at Chapel Hill 27599-7510, USA.
Abstract:
This prospective study evaluates the ability of MRI using T1-weighted fat-suppressed spin-echo (T1FS) and dynamic gadolinium chelate (Gd) enhanced spoiled-gradient echo (SGE) to detect the presence of pancreatic tumor in patients in whom spiral CT findings are inconclusive. Sixteen consecutive patients who underwent spiral CT and had findings that were considered inconclusive for pancreatic tumor underwent MR within 2 weeks of CT. Spiral CT and MR images were interpreted in prospective fashion by separate individual investigators blinded to the results of the other imaging modality. CT was performed on a spiral CT scanner. MRI was performed on on a 1.5-T MR machine. Imaging sequences included T1FS pre-Gd and post-Gd and SGE pre-Gd and immediately post-Gd. Data were analyzed using receiver operating characteristic (ROC) analysis. Confirmation was obtained by pancreatic biopsy (n = 4), surgical resection (n = 1), and clinical imaging (n = 4) or clinical follow-up (n = 7). MRI was superior to spiral CT (P = .027) in this selected patient group at detecting or excluding pancreatic tumor by ROC analysis, with areas under the curve of .982 and .764, respectively, which was significant (P = .041). The greatest advantage of MRI was in patients in whom spiral CT demonstrated enlargement of the pancreatic head without clear definition of tumor, which was significant (P = .033). In 10 patients with this CT appearance, MRI demonstrated a high confidence for presence of tumor in four and a high confidence of absence in six. Association of imaging findings with patient diagnosis was significant for MRI (P = .001) but not significant for CT (P = .148). The results of our study suggest that MRI may add significant diagnostic information in patients in whom spiral CT is inconclusive for the presence of pancreatic tumor. The greatest advantage of MRI was in the evaluation of patients in whom spiral CT findings revealed an indeterminate enlarged pancreatic head.
Insights
Magnetic resonance imaging (MRI) is superior to spiral computed tomography (CT) for detecting pancreatic tumors when CT results are inconclusive. MRI offers significant diagnostic value, especially for indeterminate pancreatic head enlargement.
Area of Science:
- Radiology
- Medical Imaging
- Oncology
Background:
- Spiral CT is a common tool for diagnosing pancreatic tumors.
- Inconclusive CT findings necessitate further diagnostic investigation.
- Early and accurate detection of pancreatic tumors is crucial for patient outcomes.
Purpose of the Study:
- To evaluate the diagnostic performance of MRI compared to spiral CT in detecting pancreatic tumors.
- To determine if MRI provides additional diagnostic information when CT findings are inconclusive.
- To assess MRI's effectiveness in cases of indeterminate pancreatic head enlargement on CT.
Main Methods:
- Prospective study comparing MRI and spiral CT in 16 patients with inconclusive CT findings.
- MRI sequences included T1-weighted fat-suppressed spin-echo (T1FS) and dynamic gadolinium-enhanced spoiled-gradient echo (SGE).
- Receiver operating characteristic (ROC) analysis was used to compare the diagnostic accuracy of both modalities.
Main Results:
- MRI demonstrated superior performance to spiral CT in detecting or excluding pancreatic tumors (AUC of 0.982 vs. 0.764, P = .041).
- MRI showed a significant advantage in evaluating patients with an enlarged pancreatic head without clear tumor definition on CT (P = .033).
- MRI findings were significantly associated with patient diagnosis (P = .001), unlike CT (P = .148).
Conclusions:
- MRI can provide significant additional diagnostic information in cases of inconclusive pancreatic tumor diagnosis by spiral CT.
- MRI is particularly valuable for evaluating indeterminate enlargement of the pancreatic head.
- This study supports the use of MRI as a complementary tool to CT for pancreatic tumor detection.